300267 尔康制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资119,657-0.48%120,229138,968146,158155,958
投资性房地产79,685-1.97%81,28885,26388,65692,048
固定资产2,552,119-1.00%2,577,8322,681,7091,983,7212,618,008
在建工程245,91511.33%220,89052,917506,179408,205
无形资产366,611-3.02%378,034406,136431,447553,348
商誉2,0030.00%2,00310,00810,00823,842
其他非流动资产369,7740.54%367,778389,666319,445119,810
3,735,766-0.33%3,748,0553,764,6683,485,6143,971,218

流动资产
货币资金638,896-14.17%744,350764,669761,564883,225
应收账款107,436-1.57%109,154133,693186,496353,786
存货691,486-0.02%691,603821,345714,772756,059
其他流动资产254,43036.86%185,907371,497283,533692,702
1,692,248-2.24%1,731,0142,091,2041,946,3652,685,773

流动负债
短期借款340,208-0.49%341,889396,641246,000463,000
应付票据0--0000
应付帐款146,13919.49%122,299198,705137,871152,233
其他流动负债99,484-28.49%139,113130,087115,056140,544
585,831-2.90%603,301725,433498,926755,777
流动资产净值1,106,417-1.89%1,127,7131,365,7711,447,4391,929,996
资产总额减流动负债4,842,182-0.69%4,875,7685,130,4394,933,0535,901,214

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债64,363-2.12%65,75479,13559,35163,058
64,363-2.12%65,75479,13559,35163,058

总权益
    实收股本2,062,6050.00%2,062,6052,062,6052,062,6052,062,605
    储备项目2,741,174-1.16%2,773,4412,988,4262,788,6073,748,437
股东权益4,803,779-0.67%4,836,0465,051,0314,851,2115,811,042
非控股权益(25,959)-0.28%(26,032)27322,49027,114